Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status
about
Diet and risk of breast cancerThe Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on BioaccessibilityHelping women to good health: breast cancer, omega-3/omega-6 lipids, and related lifestyle factorsBroad targeting of angiogenesis for cancer prevention and therapyToxic phytochemicals and their potential risks for human cancerA phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.Enterolactone Reduces Telomerase Activity and The Level of Its Catalytic Subunit in Breast Cancer Cells.Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women.Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.Dietary lignans: physiology and potential for cardiovascular disease risk reduction.Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycosideEffect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapyEffects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial.Lignans and human health.Flax and Breast Cancer: A Systematic Review.Dietary lignan intake and androgen receptor expression in breast tumors.Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.Phytoestrogen (+)-pinoresinol exerts antitumor activity in breast cancer cells with different oestrogen receptor statuses.Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors.Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women.Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.Development of an updated phytoestrogen database for use with the SWAN food frequency questionnaire: intakes and food sources in a community-based, multiethnic cohort studyDietary flavonol intake is associated with age of puberty in a longitudinal cohort of girlsLignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth.Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial.Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study.Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer.Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer.The Lignan Pinoresinol Induces Nuclear Translocation of DAF-16 in Caenorhabditis elegans but has No Effect on Life Span.Oilseeds ameliorate metabolic parameters in male mice, while contained lignans inhibit 3T3-L1 adipocyte differentiation in vitro.Dietary intake and urinary excretion of lignans in Finnish men.Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads.Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.Dietary consumption of phytochemicals and breast cancer risk in Mexican women.Risk Factors for Breast Cancer among Jordanian Women: A Case-control Study.Molecular targets of vitexin and isovitexin in cancer therapy: a critical review.The Effect of Flaxseed in Breast Cancer: A Literature Review.
P2860
Q26751985-C31C58B0-468D-43EC-9C23-C2A896D31C12Q26767195-39CAFD80-2F9D-4A16-BB51-5825E1314DF0Q26995109-7A57F263-8CFA-43C6-B7B9-98BA69D365DAQ27002903-3D82D001-7E4A-46B7-85BC-9276CA3F6F67Q28652418-2F19087D-60E7-4D2B-83BE-26761962FCF5Q33451759-DE9844A6-20F5-4DF7-B1FA-FD750F3C340DQ33738088-6B4B8F96-C6F8-40B9-AAB3-08D96EFA3FBAQ33939314-88C1DD33-FDD4-47B1-8F78-BC6D92CE2376Q34033220-236D52B2-EDCB-4394-9FA1-67D40728E4D9Q34036279-685F386E-DEEC-49A3-BC50-3A62765B8657Q34060204-FF633874-CF49-42BA-BB2D-816938D6D4DDQ34140938-21D266FD-4B52-43CD-B4D1-A707B7B7C3A6Q34203765-05D71F7D-D41C-4A2C-BDEE-C6CE827BD94AQ34334503-BEA606BD-CCB6-425E-8D00-407C5F096CE5Q34480462-E415084D-48AB-40B4-8199-D2D250FB580AQ34702636-E270E56B-EE77-454C-B25B-BA9D535AB83FQ34980961-AE05AA7B-0BB0-454B-B3D2-0BF21BE3EB7FQ34995845-5E378D5E-D244-4434-AE34-D39FF3D868F6Q35527144-786835CB-666D-4193-BAE5-36A68A92EADCQ36125656-A6A86AF8-3DC4-46D0-95AD-CDE021D09210Q36267739-F61CE505-4E5C-4525-A79C-211C4AEABD2FQ36459754-F7365297-2A3D-4606-A81D-914C942DDB7DQ36678705-5E53E9C4-A383-47D5-B0C5-6B0FD5C3AFBFQ36908475-2A105477-9FDD-47CA-91A2-793D5DEF48E5Q37017226-9CD7BF77-16E2-4664-833E-CF6C2189DE70Q37222654-F6747897-56F1-44B2-AE47-526C9FDF3C28Q37362982-FCB844F7-689A-4766-A275-20D9D140DF52Q37369803-1CAFEF00-B23A-4E01-BA80-70F874EBEEEDQ37425020-FF94D49B-3CD3-4150-83FA-59ED91BE268BQ37962472-90AC231B-6F10-4217-B706-6A889A412740Q38827460-81FB15B8-4A0C-4EBC-A470-ADEF4AF4A102Q41135905-FE522252-223D-4409-BAE2-4F4CAC757CD3Q42806244-3316091A-B283-49F8-BD17-F29FB7A103BAQ43265493-ABE91E26-8B8F-4253-B461-7632253BE032Q43538457-07588FF2-6584-4CC3-8BF4-C650993C35AFQ43561419-069E25EF-8411-45C2-94AC-C2422A3D293DQ46468802-2B6D20EF-B612-40D2-BB1C-E3C1427A1335Q47241714-CBDA8797-9100-4675-B96E-1A65553A069CQ48005330-D0B3E0C4-50F1-43C8-B68B-266AB0899E71Q50132992-59619730-52E6-4FF2-90FA-B86934CA420B
P2860
Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dietary lignan intake and post ...... d progesterone receptor status
@ast
Dietary lignan intake and post ...... d progesterone receptor status
@en
type
label
Dietary lignan intake and post ...... d progesterone receptor status
@ast
Dietary lignan intake and post ...... d progesterone receptor status
@en
prefLabel
Dietary lignan intake and post ...... d progesterone receptor status
@ast
Dietary lignan intake and post ...... d progesterone receptor status
@en
P2093
P2860
P50
P356
P1476
Dietary lignan intake and post ...... d progesterone receptor status
@en
P2093
Anne C M Thiébaut
Marina S Touillaud
Maryvonne Niravong
P2860
P304
P356
10.1093/JNCI/DJK096
P407
P577
2007-03-01T00:00:00Z